PTPN22 and type 1 diabetes mellitus: In contrast, there was sufficient statistical evidence to indicate antagonistic interaction between PTPN22 and HLA-DR on the risk of T1DM (case-only interaction OR = 0.22, 95% CI: 0.09–0.54; Table 4).